Agenda/Scientific Program
The Forum will bring together industry, regulatory, and academic professionals to discuss key emerging CMC issues that affect biotechnology. The topic for 2025 is "Bioconjugates & Multispecifics: Technologies, Analytics, Developability and Scalability". The Forum will consist of speaker presentations, panel discussions, and networking opportunities. We look forward to an informative Forum and hope to see you there. Be ready to network, collaborate, and expand your knowledge.
Bioconjugates & Multispecifics: Technologies, Analytics, Developability and Scalability
Bioconjugate and multi-specific biologics represent a diverse and innovative area in the field of biotechnology. The diversity of these targeted therapies offers significant benefit in disease prevention and treatment but can introduce complexities for development, manufacturing, supply, and testing.
This Forum aims to delve deeper into various modalities, including antibody-drug conjugates, novel bioconjugates of oligonucleotides and radionuclides, and multi-specifics to explore technologies and strategies to bring these medicines to patients. The discussion will cover development, scalability, and analytical and regulatory considerations. Understanding these aspects is crucial for advancing the field and improving product development and patient outcomes.
Frequently Asked Questions
Register Now
Save your spot for CMC North America 2025 on July 14-15, 2025 in Gaithersburg, MD. Register by June 30, 2025.
"It is a great forum to learn best industrial practices, exchange science and have open discussions with regulators on CMC challenges and strategies."
—Chunlei Wang, CMC Strategy Forum North America 2024 Attendee"The CASSS North America CMC Strategy Forum was fantastic - such great speakers and panel discussions around the wide world of bioconjugates over the entire two days!"
—Carly Daniels, CMC Strategy Forum North America 2024 Attendee